Fourteen years’ clinical experience and the first million babies protected with human live-attenuated vaccine against rotavirus disease in Italy

Fourteen years’ clinical experience and the first million babies protected with human live-attenuated vaccine against rotavirus disease in Italy

Rotavirus (RV) causes up to half of hospital and community acute gastroenteritis (AGE) cases in young children in Italy. Two RV vaccines, available since 2006, are human RV (HRV) and human bovine RV (HBRV). This report looks back at the implementation of RV vaccination with HRV in Italy, and at HRV...

Full description

Bibliographic Details
Main Authors: Paolo Bonanni, Giorgio Conforti, Elisabetta Franco, Giovanni Gabutti, Federico Marchetti, Antonella Mattei, Rosa Prato, Giovanni Vitali Rosati, Francesco Vitale
Format: Article
Language:English
Published: Taylor & Francis Group 2021-11-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
rotavirus
italy
vaccination
epidemiology
safety
impact
Online Access:http://dx.doi.org/10.1080/21645515.2021.1955611

Internet

http://dx.doi.org/10.1080/21645515.2021.1955611

Similar Items